• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个平衡的片段文库能够实现快速的合成扩展,从而产生首个被报道的针对非典型溴结构域PHIP(2)的抑制剂。

A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain.

作者信息

Cox Oakley B, Krojer Tobias, Collins Patrick, Monteiro Octovia, Talon Romain, Bradley Anthony, Fedorov Oleg, Amin Jahangir, Marsden Brian D, Spencer John, von Delft Frank, Brennan Paul E

机构信息

Structural Genomics Consortium (SGC) , University of Oxford , Oxford OX3 7DQ , UK.

Target Discovery Institute (TDI) , Nuffield Department of Medicine , University of Oxford , Oxford OX3 7FZ , UK . Email:

出版信息

Chem Sci. 2016 Mar 1;7(3):2322-2330. doi: 10.1039/c5sc03115j. Epub 2015 Dec 22.

DOI:10.1039/c5sc03115j
PMID:29910922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5977933/
Abstract

Research into the chemical biology of bromodomains has been driven by the development of acetyl-lysine mimetics. The ligands are typically anchored by binding to a highly conserved asparagine residue. Atypical bromodomains, for which the asparagine is mutated, have thus far proven elusive targets, including PHIP(2) whose parent protein, PHIP, has been linked to disease progression in diabetes and cancers. The PHIP(2) binding site contains a threonine in place of asparagine, and solution screening have yielded no convincing hits. We have overcome this hurdle by combining the sensitivity of X-ray crystallography, used as the primary fragment screen, with a strategy for rapid follow-up synthesis using a chemically-poised fragment library, which allows hits to be readily modified by parallel chemistry both peripherally and in the core. Our approach yielded the first reported hit compounds of PHIP(2) with measurable IC values by an AlphaScreen competition assay. The follow-up libraries of four poised fragment hits improved potency into the sub-mM range while showing good ligand efficiency and detailed structural data.

摘要

对溴结构域化学生物学的研究是由乙酰赖氨酸模拟物的发展推动的。这些配体通常通过与一个高度保守的天冬酰胺残基结合而锚定。对于天冬酰胺发生突变的非典型溴结构域,迄今为止已证明是难以捉摸的靶点,包括PHIP(2),其母体蛋白PHIP与糖尿病和癌症的疾病进展有关。PHIP(2)结合位点含有一个苏氨酸而非天冬酰胺,溶液筛选未产生令人信服的结果。我们通过将用作主要片段筛选的X射线晶体学的灵敏度与使用化学平衡片段库进行快速后续合成的策略相结合,克服了这一障碍,该策略允许通过平行化学在外围和核心部位对命中物进行轻松修饰。我们的方法通过AlphaScreen竞争测定法产生了首批报道的具有可测量IC值的PHIP(2)命中化合物。四个平衡片段命中物的后续库将效力提高到亚毫摩尔范围,同时显示出良好的配体效率和详细的结构数据。

相似文献

1
A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain.一个平衡的片段文库能够实现快速的合成扩展,从而产生首个被报道的针对非典型溴结构域PHIP(2)的抑制剂。
Chem Sci. 2016 Mar 1;7(3):2322-2330. doi: 10.1039/c5sc03115j. Epub 2015 Dec 22.
2
Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding Sites.BRD4 的共价片段筛选鉴定了一个与乙酰赖氨酸结合位点正交的配体结合位点。
ACS Chem Biol. 2020 Apr 17;15(4):1036-1049. doi: 10.1021/acschembio.0c00058. Epub 2020 Mar 23.
3
Fragment expansion with NUDELs - poised DNA-encoded libraries.使用NUDELs进行片段扩展——平衡的DNA编码文库。
Chem Sci. 2023 Jul 12;14(31):8288-8294. doi: 10.1039/d3sc01171b. eCollection 2023 Aug 9.
4
Structural Analysis and Development of Notum Fragment Screening Hits.结构分析和诺图片段筛选命中物的开发。
ACS Chem Neurosci. 2022 Jul 6;13(13):2060-2077. doi: 10.1021/acschemneuro.2c00325. Epub 2022 Jun 22.
5
Straightforward hit identification approach in fragment-based discovery of bromodomain-containing protein 4 (BRD4) inhibitors.基于片段的溴结构域蛋白 4(BRD4)抑制剂发现中的直接命中鉴定方法。
Bioorg Med Chem. 2018 Jul 23;26(12):3399-3405. doi: 10.1016/j.bmc.2018.05.010. Epub 2018 May 9.
6
Evaluating the Advantages of Using 3D-Enriched Fragments for Targeting BET Bromodomains.评估使用富含3D结构的片段靶向BET溴结构域的优势。
ACS Med Chem Lett. 2019 Nov 22;10(12):1648-1654. doi: 10.1021/acsmedchemlett.9b00414. eCollection 2019 Dec 12.
7
Application of Atypical Acetyl-lysine Methyl Mimetics in the Development of Selective Inhibitors of the Bromodomain-Containing Protein 7 (BRD7)/Bromodomain-Containing Protein 9 (BRD9) Bromodomains.非典型乙酰赖氨酸甲基模拟物在开发包含溴结构域蛋白 7(BRD7)/包含溴结构域蛋白 9(BRD9)溴结构域的选择性抑制剂中的应用。
J Med Chem. 2020 Jun 11;63(11):5816-5840. doi: 10.1021/acs.jmedchem.0c00075. Epub 2020 May 29.
8
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.针对CBP/p300溴结构域的小分子配体的发现与优化。
J Am Chem Soc. 2014 Jul 2;136(26):9308-19. doi: 10.1021/ja412434f. Epub 2014 Jun 19.
9
The "Gatekeeper" Residue Influences the Mode of Binding of Acetyl Indoles to Bromodomains.“守门员”残基影响乙酰吲哚与溴结构域的结合模式。
J Med Chem. 2016 Apr 14;59(7):3087-97. doi: 10.1021/acs.jmedchem.5b01757. Epub 2016 Mar 30.
10
Design, quality and validation of the EU-OPENSCREEN fragment library poised to a high-throughput screening collection.欧盟开放筛选片段库的设计、质量与验证,旨在打造高通量筛选集。
RSC Med Chem. 2024 Feb 12;15(4):1176-1188. doi: 10.1039/d3md00724c. eCollection 2024 Apr 24.

引用本文的文献

1
Crystallographic fragment screening reveals ligand hotspots in TRIM21 PRY-SPRY domain.晶体学片段筛选揭示了TRIM21 PRY-SPRY结构域中的配体热点。
Commun Chem. 2025 Jun 13;8(1):185. doi: 10.1038/s42004-025-01574-3.
2
MR-Based Drug Discovery Pipeline Presented on the Oncogenic Protein KRAS.基于磁共振成像的药物发现流程:以致癌蛋白KRAS为例
J Am Chem Soc. 2025 Apr 23;147(16):13200-13209. doi: 10.1021/jacs.4c16762. Epub 2025 Apr 14.
3
Status and perspective of protein crystallography at the first multi-bend achromat based synchrotron MAX IV.

本文引用的文献

1
Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant p53.利用瞬时蛋白质状态设计突变型p53的小分子稳定剂。
Structure. 2015 Dec 1;23(12):2246-2255. doi: 10.1016/j.str.2015.10.016.
2
LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor.LP99:首个选择性BRD7/9溴结构域抑制剂的发现与合成。
Angew Chem Int Ed Engl. 2015 May 18;54(21):6217-21. doi: 10.1002/anie.201501394. Epub 2015 Apr 13.
3
Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.
基于首个多弯铁消色差器的同步加速器MAX IV的蛋白质晶体学现状与展望。
J Synchrotron Radiat. 2025 May 1;32(Pt 3):779-791. doi: 10.1107/S1600577525002255. Epub 2025 Apr 4.
4
Structural Biology for Target Identification and Validation.用于靶点识别与验证的结构生物学
Methods Mol Biol. 2025;2905:17-49. doi: 10.1007/978-1-0716-4418-8_2.
5
PDBe tools for an in-depth analysis of small molecules in the Protein Data Bank.蛋白质数据库中用于小分子深入分析的PDBe工具。
Protein Sci. 2025 Apr;34(4):e70084. doi: 10.1002/pro.70084.
6
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors.寨卡病毒NS2B-NS3蛋白酶的晶体学片段筛选和深度突变扫描助力开发抗耐药性抑制剂。
Res Sq. 2025 Feb 13:rs.3.rs-5876218. doi: 10.21203/rs.3.rs-5876218/v1.
7
Enhanced identification of small molecules binding to hnRNPA1 via cryptic pockets mapping coupled with X-ray fragment screening.通过隐蔽口袋图谱绘制结合X射线片段筛选增强对与hnRNPA1结合的小分子的鉴定。
J Biol Chem. 2025 Apr;301(4):108335. doi: 10.1016/j.jbc.2025.108335. Epub 2025 Feb 19.
8
Structural insights into human brachyury DNA recognition and discovery of progressible binders for cancer therapy.人类短尾相关蛋白DNA识别的结构见解及用于癌症治疗的可进展性结合剂的发现。
Nat Commun. 2025 Feb 14;16(1):1596. doi: 10.1038/s41467-025-56213-1.
9
Binding-Site Purification of Actives (B-SPA) Enables Efficient Large-Scale Progression of Fragment Hits by Combining Multi-Step Array Synthesis With HT Crystallography.活性物质结合位点纯化(B-SPA)通过将多步阵列合成与高通量晶体学相结合,实现了片段命中物的高效大规模推进。
Angew Chem Int Ed Engl. 2025 Apr 11;64(16):e202424373. doi: 10.1002/anie.202424373. Epub 2025 Mar 18.
10
Macromolecular crystallography from an industrial perspective - the impact of synchrotron radiation on structure-based drug discovery.从工业角度看大分子晶体学——同步辐射对基于结构的药物发现的影响。
J Synchrotron Radiat. 2025 Mar 1;32(Pt 2):294-303. doi: 10.1107/S1600577524012281. Epub 2025 Feb 6.
I-BRD9的发现,一种用于抑制含溴结构域蛋白9的选择性细胞活性化学探针。
J Med Chem. 2016 Feb 25;59(4):1425-39. doi: 10.1021/acs.jmedchem.5b00256. Epub 2015 Apr 30.
4
Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.GSK2801的发现与特性研究,一种针对BAZ2A和BAZ2B溴结构域的选择性化学探针
J Med Chem. 2016 Feb 25;59(4):1410-24. doi: 10.1021/acs.jmedchem.5b00209. Epub 2015 Apr 6.
5
Structure enabled design of BAZ2-ICR, a chemical probe targeting the bromodomains of BAZ2A and BAZ2B.基于结构设计的BAZ2-ICR,一种靶向BAZ2A和BAZ2B溴结构域的化学探针。
J Med Chem. 2015 Mar 12;58(5):2553-9. doi: 10.1021/jm501963e. Epub 2015 Feb 26.
6
Large scale meta-analysis of fragment-based screening campaigns: privileged fragments and complementary technologies.基于片段筛选研究的大规模荟萃分析:优势片段与互补技术
J Biomol Screen. 2015 Jun;20(5):588-96. doi: 10.1177/1087057114565080. Epub 2014 Dec 30.
7
Small molecule inhibitors of bromodomain-acetyl-lysine interactions.溴结构域-乙酰赖氨酸相互作用的小分子抑制剂
ACS Chem Biol. 2015 Jan 16;10(1):22-39. doi: 10.1021/cb500996u.
8
Efficient exploration of chemical space by fragment-based screening.基于片段筛选的化学空间高效探索
Prog Biophys Mol Biol. 2014 Nov-Dec;116(2-3):82-91. doi: 10.1016/j.pbiomolbio.2014.09.007. Epub 2014 Sep 28.
9
The discovery of I-BET726 (GSK1324726A), a potent tetrahydroquinoline ApoA1 up-regulator and selective BET bromodomain inhibitor.I-BET726(GSK1324726A)的发现,它是一种有效的四氢喹啉载脂蛋白A1上调剂和选择性BET溴结构域抑制剂。
J Med Chem. 2014 Oct 9;57(19):8111-31. doi: 10.1021/jm5010539. Epub 2014 Sep 24.
10
Advantages of crystallographic fragment screening: functional and mechanistic insights from a powerful platform for efficient drug discovery.晶体学片段筛选的优势:来自高效药物发现强大平台的功能和机制见解。
Prog Biophys Mol Biol. 2014 Nov-Dec;116(2-3):92-100. doi: 10.1016/j.pbiomolbio.2014.08.004. Epub 2014 Aug 10.